Searched for: in-biosketch:true
person:naruln01
Impact of the New WHO Classification of Thymic Tumors: Cross-Validation of the Prognostic Value in a Single Institution Cohort [Meeting Abstract]
Kamel, Mohamed; Narula, Navneet; Port, Jeffrey; Stiles, Brendon; Altorki, Nasser
ISI:000413055803316
ISSN: 1556-0864
CID: 3151882
Scedosporium apiospermum Mycetoma in an Immunocompetent Patient without Prior Lung Disease [Letter]
Ma, Kevin C.; Pino, Alejandro; Narula, Navneet; Turetz, Meredith L.
ISI:000419015400024
ISSN: 1546-3222
CID: 3151892
A Woman with a Breast Mass, Multiple Pulmonary Nodules, and Wheezing
O'Beirne, Sarah L; Legasto, Alan C; Narula, Navneet; Giorgadze, Tamara A; Gelbman, Brian D
PMID: 28035883
ISSN: 2325-6621
CID: 2768582
Scedosporium apiospermum Mycetoma in an Immunocompetent Patient without Prior Lung Disease
Ma, Kevin C; Pino, Alejandro; Narula, Navneet; Turetz, Meredith L
PMID: 28035880
ISSN: 2325-6621
CID: 3087532
Classification of cardiomyopathies
Chapter by: Narula, Jagat; Maron, B; Narula, Navneet; Arbustini, E
in: Hurst's the heart by Fuster, Valentin; Harrington, Robert A; Narula, Jagat; Eapen, Zubin J (Eds)
New York : McGraw-Hill Education, 2017
pp. ?-?
ISBN: 0071844376
CID: 3149592
(99mT)c-duramycin Imaging Detects Cancer Therapy Related Cardiac Dysfunction Before a Decrease in Lvef [Meeting Abstract]
Nakahara, Takehiro; Petrov, Artiom D.; Tanimoto, Takashi; Haider, Nezam; Narula, Navneet; Chaudhry, Farhan; Mattis, Jeffrey A.; Pak, Koon Y.; Sahni, Gagan; Tiersten, Amy; Bhardwaj, Aarti; Sengupta, Partho P.; Dweck, Marc R.; Strauss, Harry W.; Narula, Jagat
ISI:000396815603133
ISSN: 0009-7322
CID: 3151832
Microvascular Integrity in Myocardial Injury: The Irony of Iron Deposition [Editorial]
Narula, Navneet; Narula, Nupoor; Ahmadi, Amir
PMID: 27903549
ISSN: 1942-0080
CID: 2768612
PS01.26: Prognostic Value of the New WHO Thymoma Classification: Single Institution Cross Validation Study: Topic: Pathology
Kamel, Mohamed; Narula, Navneet; Port, Jeffrey L; Stiles, Brendon M; Altorki, Nasser K
PMID: 27969493
ISSN: 1556-1380
CID: 3147352
Anatomical Segmentectomy and Wedge Resections Are Associated with Comparable Outcomes for Patients with Small cT1N0 Non-Small Cell Lung Cancer
Altorki, Nasser K; Kamel, Mohamed K; Narula, Navneet; Ghaly, Galal; Nasar, Abu; Rahouma, Mohamed; Lee, Paul C; Port, Jeffery L; Stiles, Brendon M
OBJECTIVES: Sublobar resection is advocated for patients with NSCLC and compromised cardiopulmonary reserve, and for selected patients with early stage disease. Anatomic segmentectomy (AS) has traditionally been considered superior to wedge resection (WR), but well-balanced comparative studies are lacking. We hypothesize that WR and AS are associated with comparable oncologic outcomes for patients with cT1N0 NSCLC. METHODS: A retrospective review of a prospective database was performed (2000-2014) for cT1N0 patients, excluding patients with multiple primary tumors, carcinoid tumors, adenocarcinoma in situ, and minimally invasive adenocarcinoma. Demographic, clinical, and pathological data were reviewed. Overall survival (OS) and disease-free survival (DFS) were estimated using the Kaplan-Meier method and differences compared using log-rank test. Multivariable analysis (MVA) of factors affecting DFS was performed by Cox regression analysis. For further comparison of the effect of resection type on survival, propensity score matching (i.e., by age, sex, Charlson comorbidity index, percent forced expiratory volume in 1 second (FEV1%), clinical tumor size, and tumor maximum standardized uptake value) was performed to obtain balanced cohorts of patients undergoing WR and AS (n = 76 per group). RESULTS: Two hundred eighty-nine patients met our selection criteria, including WR in 160 and AS in 129. Poor performance status and limited cardiopulmonary reserve were the primary indications for sublobar resection in 76% of WR patients and in 62% of AS patients (p = 0.011). Thirteen patients (4.5%) had pN1/2 disease. Patients undergoing AS were more likely to have nodal sampling/dissection [123 (95%) versus 112 (70%); p < 0.001], more stations sampled (3 versus 2; p < 0.001), and more total nodes resected (7 versus 4; p = 0.001). However, there was no difference between patients undergoing WR versus AS in local recurrence [15 versus 14; p = 0.68] or 5-year DFS (51% versus 53%; p = 0.7; median follow-up 34 months). Univariate analysis showed no effect of extent of resection on DFS [hazard ratio 1.07 (95% confidence interval 0.74-1.56); p = 0.696]. MVA showed that only tumor maximum standardized uptake value was associated with worse DFS [hazard ratio 1.07 (95% confidence interval 1.01-1.13); p = 0.016]. In the propensity-matched analysis of balanced subgroups, there was also no difference (p = 0.950) in 3- or 5-year DFS in cT1N0 patients undergoing WR (65% and 49%) or AS (68% and 49%). CONCLUSIONS: Our data show that WR and AS are comparable oncologic procedures for carefully staged cT1N0 NSCLC patients. Although AS is associated with a more thorough lymph node dissection, this did not translate to a survival benefit in this patient population with a low rate of nodal metastases.
PMID: 27496651
ISSN: 1556-1380
CID: 2768622
Rho Kinase Ezpression in Giant Cell Arteritis: Validating Perm Intensity Score As a Method of Increasing Sensitivity of Temporal Artery Biopsy [Meeting Abstract]
Lally, Lindsay; Narula, Navneet; Goodfellow, Nicola; Luqmani, Raashid; Spiera, Robert F.
ISI:000417143401260
ISSN: 2326-5191
CID: 3150652